| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 15,126 | 15,201 | 14,691 | 13,933 | | Cost of Revenue | 4,404 | 4,938 | 5,263 | 5,658 | | | Gross Profit |
-
| 10,263 | 9,428 | 8,275 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,167 | 7,684 | 9,677 | 7,379 | | Non Recurring |
-
| 373 |
-
|
-
| | Others | 694 | 444 | 670 | 2,907 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 1,762 | (919) | (2,011) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 3,259 | 1,764 | (946) | (2,084) | | Interest Expense | 507 | 509 | 532 | 526 | | Income Before Tax | 2,752 | 1,255 | (1,478) | (2,610) | | Income Tax Expense | 864 | 293 | (370) | (896) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,980 | 962 | (1,108) | (1,714) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,888 | 962 | (1,108) | (1,714) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,888 | $962 | ($1,108) | ($1,714) |
|
0.51% Nasdaq 
Income Statement
